Logan Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-155,114
Closed -$17.9M 433
2025
Q4
$16.3M Sell
155,114
-3,703
-2% -$348K 0.69% 33
2025
Q3
$13.3M Buy
158,817
+145
+0.1% +$11.9K 0.56% 45
2025
Q2
$12.6M Sell
158,672
-7,798
-5% -$620K 0.58% 45
2025
Q1
$14.9M Buy
166,470
+2,750
+2% +$257K 0.68% 43
2024
Q4
$16.3M Sell
163,720
-208
-0.1% -$21.4K 0.68% 39
2024
Q3
$18.6M Sell
163,928
-308
-0.2% -$36.6K 0.77% 33
2024
Q2
$20.3M Sell
164,236
-37
-0% -$4.77K 0.88% 24
2024
Q1
$21.7M Sell
164,273
-833
-0.5% -$103K 0.93% 27
2023
Q4
$18M Buy
165,106
+34
+0% +$3.53K 0.84% 31
2023
Q3
$17M Sell
165,072
-45
-0% -$4.85K 0.86% 29
2023
Q2
$19.1M Sell
165,117
-5,243
-3% -$595K 0.91% 25
2023
Q1
$18.1M Sell
170,360
-1,402
-0.8% -$151K 0.88% 29
2022
Q4
$19.1M Buy
171,762
+41,843
+32% +$4.28M 0.98% 24
2022
Q3
$11.2M Buy
129,919
+522
+0.4% +$46.6K 0.67% 49
2022
Q2
$11.8M Buy
129,397
+1,171
+0.9% +$104K 0.68% 48
2022
Q1
$10.5M Buy
128,226
+249
+0.2% +$19.6K 0.51% 60
2021
Q4
$9.81M Sell
127,977
-4,201
-3% -$335K 0.42% 71
2021
Q3
$9.93M Buy
132,178
+1,984
+2% +$151K 0.46% 70
2021
Q2
$10.1M Sell
130,194
-8,181
-6% -$609K 0.47% 71
2021
Q1
$10.2M Sell
138,375
-253
-0.2% -$18.7K 0.51% 64
2020
Q4
$10.8M Sell
138,628
-1,592
-1% -$122K 0.54% 57
2020
Q3
$11.1M Sell
140,220
-806
-0.6% -$63.1K 0.6% 45
2020
Q2
$10.4M Buy
141,026
+673
+0.5% +$50.7K 0.6% 54
2020
Q1
$10.3M Buy
140,353
+2,947
+2% +$232K 0.72% 42
2019
Q4
$11.9M Sell
137,406
-293
-0.2% -$24.1K 0.65% 47
2019
Q3
$11.1M Sell
137,699
-251
-0.2% -$20.1K 0.65% 46
2019
Q2
$11M Sell
137,950
-3,917
-3% -$300K 0.65% 47
2019
Q1
$11.3M Sell
141,867
-27,284
-16% -$2.04M 0.69% 43
2018
Q4
$12.3M Sell
169,151
-102,839
-38% -$7.26M 0.97% 28
2018
Q3
$18.4M Buy
271,990
+1,230
+0.5% +$78.4K 1.21% 25
2018
Q2
$15.7M Buy
270,760
+10,434
+4% +$589K 1.09% 28
2018
Q1
$13.5M Buy
260,326
+99,349
+62% +$5.37M 0.95% 34
2017
Q4
$8.64M Buy
160,977
+33,731
+27% +$1.87M 0.61% 49
2017
Q3
$7.77M Buy
127,246
+5,146
+4% +$312K 0.56% 55
2017
Q2
$7.47M Sell
122,100
-976
-0.8% -$59.4K 0.56% 62
2017
Q1
$7.46M Sell
123,076
-28,815
-19% -$1.75M 0.58% 57
2016
Q4
$8.53M Buy
151,891
+3,953
+3% +$231K 0.69% 50
2016
Q3
$8.81M Sell
147,938
-5,089
-3% -$298K 0.72% 49
2016
Q2
$8.41M Sell
153,027
-191,204
-56% -$10.2M 0.71% 52
2016
Q1
$17.4M Buy
344,231
+59,684
+21% +$2.92M 1.4% 23
2015
Q4
$14.3M Sell
284,547
-125
-0% -$6.3K 1.14% 32
2015
Q3
$13.4M Sell
284,672
-8,930
-3% -$474K 1.12% 33
2015
Q2
$15.9M Sell
293,602
-28,261
-9% -$1.58M 1.17% 29
2015
Q1
$17.7M Buy
321,863
+522
+0.2% +$29.6K 1.24% 24
2014
Q4
$17.4M Sell
321,341
-11,767
-4% -$656K 1.26% 24
2014
Q3
$18.8M Sell
333,108
-1,784
-0.5% -$100K 1.35% 24
2014
Q2
$18.5M Sell
334,892
-14,050
-4% -$766K 1.31% 27
2014
Q1
$18.9M Sell
348,942
-5,619
-2% -$291K 1.36% 22
2013
Q4
$16.9M Buy
354,561
+40,422
+13% +$1.85M 1.2% 29
2013
Q3
$14.3M Buy
314,139
+3,419
+1% +$156K 1.07% 38
2013
Q2
$12.4M Buy
+310,720
New +$13.9M 1% 42

Other funds holding MRK

Logan Capital Management's MRK Position: Q1 2026 in Review

Logan Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 155,114 shares — an estimated $17.9M sold.

Logan Capital Management first reported a position in MRK in Q2 2013 and held it in 51 quarters. The position peaked at $21.7M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Logan Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 155,114 Merck shares in Q1 2026, an estimated $17.9M.
  • Logan Capital Management first reported a position in Merck in Q2 2013 and held it in 51 quarters.
  • Logan Capital Management's Merck position peaked at $21.7M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.